https://cureangelman.org/clinical-trials/a-study-to-investigate-the-safety-tolerability-pharmacokinetics-pk-and-pharmacodynamics-pd-of-ro7248824-in-participants-with-angelman-syndrome-as/ 2026-10-25T19:11:28+00:00 https://cureangelman.org/clinical-trials/natural-history-study-for-patients-with-angelman-syndrome/ 2026-10-25T19:12:21+00:00 https://cureangelman.org/clinical-trials/families-of-youth-with-developmental-disabilities-a-theory-based-intervention/ 2026-10-25T19:13:12+00:00 https://cureangelman.org/clinical-trials/a-natural-history-study-of-angelman-syndrome-glow-as/ 2026-10-25T19:24:46+00:00 https://cureangelman.org/clinical-trials/transcriptomic-analysis-of-fibroblasts-and-blood-in-patients-with-rare-diseases/ 2026-10-25T19:36:28+00:00 https://cureangelman.org/clinical-trials/a-study-of-the-safety-and-tolerability-of-gtx-102-in-children-with-angelman-syndrome/ 2026-10-25T19:44:38+00:00 https://cureangelman.org/clinical-trials/halos-a-safety-tolerability-pharmacokinetics-and-pharmacodynamics-study-of-multiple-ascending-doses-of-ion582-in-participants-with-angelman-syndrome/ 2026-10-25T19:47:30+00:00 https://cureangelman.org/clinical-trials/an-open-label-study-of-the-safety-tolerability-and-pharmacokinetics-of-oral-nnz-2591-in-angelman-syndrome/ 2026-10-25T19:48:27+00:00 https://cureangelman.org/clinical-trials/phase-3-efficacy-and-safety-study-of-gtx-102-in-pediatric-subjects-with-angelman-syndrome-as/ 2026-10-25T19:50:06+00:00 https://cureangelman.org/clinical-trials/angelman-syndrome-natural-history-study/ 2026-10-25T19:50:43+00:00 https://cureangelman.org/clinical-trials/long-term-extension-of-gtx-102-in-angelman-syndrome/ 2026-10-25T19:51:41+00:00 https://cureangelman.org/clinical-trials/web-intervention-for-parents-of-youth-with-genetic-syndromes-wings/ 2026-10-25T19:52:11+00:00 https://cureangelman.org/clinical-trials/a-safety-and-efficacy-study-of-gtx-102-in-subjects-with-deletion-or-nondeletion-type-angelman-syndrome-as/ 2026-10-25T19:53:04+00:00 https://cureangelman.org/clinical-trials/a-phase-1-2-study-of-the-safety-and-efficacy-of-mvx-220-in-angelman-syndrome/ 2026-10-25T19:53:55+00:00 https://cureangelman.org/clinical-trials/reveal-a-phase-3-study-of-obudanersen-ion582-in-angelman-syndrome/ 2026-10-25T19:55:53+00:00 https://cureangelman.org/clinical-trials/expanded-access-compassionate-use-of-rugonersen-in-patients-with-angelman-syndrome/ 2026-10-25T20:01:51+00:00 https://cureangelman.org/clinical-trials/registry-and-natural-history-of-epilepsy-dyskinesia-syndromes/ 2026-10-25T20:02:45+00:00 https://cureangelman.org/clinical-trials/parent-and-infant-interxaction-intervention-pixi/ 2026-10-25T20:03:07+00:00 https://cureangelman.org/clinical-trials/a-retrospective-survey-based-multicenter-study-to-delineate-the-molecular-and-phenotypic-spectrum-of-epilepsy-dyskinesia-syndromes/ 2026-10-25T20:05:00+00:00 https://cureangelman.org/clinical-trials/use-of-eye-tracking-to-study-social-perception-abnormalities-in-children-with-angelman-syndrome/ 2026-10-25T20:06:13+00:00 https://cureangelman.org/clinical-trials/structural-functional-connectome-in-drug-resistant-epilepsies-and-neurodevelopmental-syndromes-with-epilepsy/ 2026-10-25T20:07:35+00:00 https://cureangelman.org/clinical-trials/the-global-angelman-syndrome-registry/ 2026-10-25T20:18:42+00:00 https://cureangelman.org/clinical-trials/angelman-natural-history-study-fast-spain/ 2026-10-25T20:20:03+00:00 https://cureangelman.org/clinical-trials/idmet-radico-cohort-radico-idmet/ 2026-10-25T20:20:30+00:00 https://cureangelman.org/clinical-trials/beacon-phase-iii-clinical-study-of-rugonersen-in-angelman-syndrome/ 2026-10-26T17:15:15+00:00 https://cureangelman.org/clinical-trials/champion-a-study-to-evaluate-the-efficacy-and-safety-of-obudanersen-ion582-in-children-and-adults-with-angelman-syndrome-as/ 2026-10-26T17:18:15+00:00